Cvs Health Corporation (CVS) |
|
|
|
Cvs Health Income Statement Quarterly
CVS
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
Premiums Earned, Net |
21,260.00 |
21,631.00 |
|
18,984.00 |
18,983.00 |
Revenue From Contract With Customer Excluding Assessed Tax |
56,794.00 |
52,522.00 |
|
51,853.00 |
50,525.00 |
Other Revenue |
2,582.00 |
2,673.00 |
|
2,957.00 |
3,108.00 |
Total Revenue |
80,636.00 |
76,826.00 |
76,604.00 |
73,794.00 |
72,616.00 |
Cost of Goods and Services Sold |
49,290.00 |
45,509.00 |
46,378.00 |
45,011.00 |
43,520.00 |
Policyholder Benefits and Claims Incurred, Net, Health |
17,606.00 |
17,951.00 |
16,574.00 |
16,081.00 |
15,901.00 |
Gross
Profit |
13,740.00 |
13,366.00 |
13,652.00 |
12,702.00 |
13,195.00 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Goodwill, Impairment Loss |
- |
- |
- |
431.00 |
- |
Other operatinig exp. /-income |
9,171.00 |
9,876.00 |
-17,791.00 |
- |
8,869.00 |
Share based plans expense |
- |
- |
- |
- |
- |
Operating Expenses Excluding Goodwill Impairments |
- |
- |
-9,210.00 |
9,210.00 |
- |
Store Impairment Charges |
- |
- |
1,358.00 |
- |
- |
Operating Expenses Excluding Store Impairments And Goodwill Impairments |
- |
- |
37,066.00 |
- |
- |
Total operating costs including COS |
76,067.00 |
73,336.00 |
74,375.00 |
70,733.00 |
68,290.00 |
Operating income/-loss
|
4,569.00 |
3,490.00 |
2,229.00 |
3,061.00 |
4,326.00 |
Other Deductions / - Income |
Interest expense |
583.00 |
586.00 |
608.00 |
602.00 |
636.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
583.00 |
586.00 |
608.00 |
602.00 |
636.00 |
Extinguishment of Debt |
- |
- |
-89.00 |
-363.00 |
- |
Net Investment Income |
-146.00 |
-168.00 |
-1,539.00 |
246.00 |
-289.00 |
Income from affiliates |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
103.00 |
126.00 |
1,679.00 |
431.00 |
244.00 |
Total costs & expenses |
76,607.00 |
73,880.00 |
75,034.00 |
71,649.00 |
68,881.00 |
Income /-loss before income taxes |
4,029.00 |
2,946.00 |
1,570.00 |
2,145.00 |
3,735.00 |
Income taxes expenses/-benefit |
1,068.00 |
633.00 |
274.00 |
558.00 |
944.00 |
Income after income taxes |
2,961.00 |
2,313.00 |
1,296.00 |
1,587.00 |
2,791.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
2,961.00 |
2,313.00 |
1,296.00 |
1,587.00 |
2,791.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
2,961.00 |
2,313.00 |
1,296.00 |
1,587.00 |
2,791.00 |
Noncontrolling interests |
-10.00 |
-1.00 |
10.00 |
11.00 |
-8.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
2,951.00 |
2,312.00 |
1,306.00 |
1,598.00 |
2,783.00 |
EBIT |
4,612.00 |
3,532.00 |
2,178.00 |
2,747.00 |
4,371.00 |
EBITD |
5,699.00 |
4,587.00 |
3,293.00 |
3,881.00 |
5,508.00 |
EBITDA |
5,699.00 |
4,587.00 |
3,293.00 |
3,881.00 |
5,508.00 |
Per
Share (GAAP Quarterly, in $) |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
Basic EPS (excl. extra
items) |
2.25 |
1.76 |
0.99 |
1.21 |
2.11 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
2.25 |
1.76 |
0.99 |
1.21 |
2.11 |
Basic shares outstanding (Mill.
of Units) |
1,313.00 |
1,312.00 |
1,323.00 |
1,321.00 |
1,319.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
2.23 |
1.74 |
0.98 |
1.20 |
2.10 |
Diluted average shares (Mill.
of Units) |
1,321.00 |
1,328.00 |
1,338.00 |
1,329.00 |
1,327.00 |
Dividend per share |
0.55 |
0.55 |
0.5 |
0.5 |
0.5 |
|
|